XPhyto Therapeutics Corp.: XPhyto Announces Head of Sales, Europe

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 17, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of

Related Keywords

Germany ,United States ,Canada ,Uttenweiler ,Baden Wüberg ,Vancouver ,British Columbia ,America ,German ,Canadian ,Drahoslav Zdarek ,Hugh Rogers ,Knox Henderson ,Pharma Gmb ,Heinrich Jehle ,Roland Spleiss ,Thomas Beckert ,Teva Pharmaceutical ,Company German Ce Mark ,Head Of Diagnostic Research ,Xphyto Therapeutics Corp ,Company Head Of Sales ,European Union ,Business Development ,Head Of Business Development ,Cell Pharma Gmbh ,Stada Arzneimittel ,North America ,Market Regulator ,Xphyto ,Herapeutics ,Orp ,Nnounces ,Head ,Sales ,Europe ,